PH14793A - Triazine derivatives - Google Patents

Triazine derivatives

Info

Publication number
PH14793A
PH14793A PH22523A PH22523A PH14793A PH 14793 A PH14793 A PH 14793A PH 22523 A PH22523 A PH 22523A PH 22523 A PH22523 A PH 22523A PH 14793 A PH14793 A PH 14793A
Authority
PH
Philippines
Prior art keywords
alkyl
radical
phenyl
monocyclic
cycloalkyl
Prior art date
Application number
PH22523A
Other languages
English (en)
Inventor
Edward Douglas Brown
Original Assignee
Ici Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ici Ltd filed Critical Ici Ltd
Publication of PH14793A publication Critical patent/PH14793A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/38—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/26—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hetero atoms directly attached to ring carbon atoms
    • C07D251/40—Nitrogen atoms
    • C07D251/42—One nitrogen atom
    • C07D251/46—One nitrogen atom with oxygen or sulfur atoms attached to the two other ring carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
PH22523A 1978-05-26 1979-05-21 Triazine derivatives PH14793A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB2293878 1978-05-26

Publications (1)

Publication Number Publication Date
PH14793A true PH14793A (en) 1981-12-09

Family

ID=10187501

Family Applications (1)

Application Number Title Priority Date Filing Date
PH22523A PH14793A (en) 1978-05-26 1979-05-21 Triazine derivatives

Country Status (24)

Country Link
US (1) US4254122A (pt)
EP (1) EP0005911B1 (pt)
JP (1) JPS54154779A (pt)
AT (1) ATE698T1 (pt)
AU (1) AU529948B2 (pt)
CA (1) CA1108138A (pt)
CS (1) CS213377B2 (pt)
DD (1) DD143906A5 (pt)
DE (1) DE2962124D1 (pt)
DK (1) DK213179A (pt)
ES (1) ES480932A1 (pt)
FI (1) FI66180C (pt)
GR (1) GR68185B (pt)
HU (1) HU180252B (pt)
IE (1) IE49170B1 (pt)
IL (1) IL57324A (pt)
MW (1) MW1379A1 (pt)
NO (1) NO791722L (pt)
NZ (1) NZ190402A (pt)
PH (1) PH14793A (pt)
PT (1) PT69650A (pt)
ZA (1) ZA792247B (pt)
ZM (1) ZM4579A1 (pt)
ZW (1) ZW9179A1 (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8629567D0 (en) * 1986-12-10 1987-01-21 Boots Co Plc Therapeutic agents
US6348216B1 (en) * 1996-06-10 2002-02-19 Knoll Pharmaceutical Company Ibuprofen and narcotic analgesic compositions
US6361794B1 (en) 1996-06-12 2002-03-26 Basf Corporation Method of making ibuprofen and narcotic analgesic composition
WO1998049150A1 (en) * 1997-04-25 1998-11-05 Takeda Chemical Industries, Ltd. Triazine derivatives, their production and agrochemical composition
US6335339B1 (en) 1998-01-13 2002-01-01 Scriptgen Pharmaceuticals, Inc. Triazine antiviral compounds
US20060166872A1 (en) * 2002-04-17 2006-07-27 Jabbour Henry N Fp receptor antagonists or pgf2 alpha antagonists for treating menorrhagia
EP1660072A2 (en) * 2003-07-29 2006-05-31 Universitätsklinikum Münster Means and methods for treating a disease which is associated with an excess transport of hyaluronan across a lipid bilayer
US7199156B2 (en) * 2003-10-10 2007-04-03 Milos Chvapil Composition and method to treat solid tumors
TW200517114A (en) * 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
CA2652773A1 (en) * 2006-05-22 2007-12-06 Combinatorx, Incorporated Methods and compositions for the treatment of diseases or conditions associated with increased c-reactive protein, interleukin-6, or interferon-gamma levels
CA2737131A1 (en) * 2007-09-19 2009-03-26 Zalicus Inc. Therapeutic regimens for the treatment of immunoinflammatory disorders
JP2011506607A (ja) * 2007-12-17 2011-03-03 ザリカス インコーポレイティッド 免疫炎症性障害の処置のための治療法
PL2399910T3 (pl) 2009-02-13 2014-09-30 Shionogi & Co Pochodne triazyny jako antagoniści receptora p2x3 i/albo p2x2/3 i kompozycja farmaceutyczna zawierająca je
US9212130B2 (en) 2010-08-10 2015-12-15 Shionogi & Co., Ltd. Heterocyclic derivative and pharmaceutical composition comprising the same
KR101867110B1 (ko) 2010-08-10 2018-06-12 시오노기 앤드 컴파니, 리미티드 트라이아진 유도체 및 그것을 함유하는 진통 작용을 갖는 의약 조성물
WO2013118855A1 (ja) 2012-02-09 2013-08-15 塩野義製薬株式会社 複素環および炭素環誘導体
TWI637949B (zh) 2013-06-14 2018-10-11 塩野義製藥股份有限公司 胺基三衍生物及含有其等之醫藥組合物
WO2022162689A1 (en) * 2021-01-26 2022-08-04 Council Of Scientific And Industrial Research Triazine-based self-assembling system

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3983116A (en) * 1973-04-05 1976-09-28 E. I. Du Pont De Nemours And Company Herbicidal triazines
US4035365A (en) * 1973-11-01 1977-07-12 Imperial Chemical Industries Limited Triazinediones
GB1464248A (en) 1973-11-01 1977-02-09 Ici Ltd Substituted triazinediones their preparation and use as herbicides
GB1543037A (en) * 1975-02-05 1979-03-28 Ici Ltd Selective herbicidal triazine-diones
US4082536A (en) * 1973-11-01 1978-04-04 Imperial Chemical Industries Limited Heterocyclic compounds and their use as pesticides
GB1504304A (en) * 1974-02-15 1978-03-15 Ici Ltd Process of combating fungal and bacterial infections of plants with triazine dione derivatives
GB1599518A (en) * 1977-02-21 1981-10-07 Ici Ltd 1,3,5-triazine-2,6-diones and pharmaceutical compositions thereof

Also Published As

Publication number Publication date
EP0005911B1 (en) 1982-02-17
ZA792247B (en) 1980-05-28
AU529948B2 (en) 1983-06-30
IE790889L (en) 1979-11-26
CA1108138A (en) 1981-09-01
DK213179A (da) 1979-11-27
GR68185B (pt) 1981-11-09
ATE698T1 (de) 1982-03-15
EP0005911A1 (en) 1979-12-12
IE49170B1 (en) 1985-08-21
US4254122A (en) 1981-03-03
JPS54154779A (en) 1979-12-06
PT69650A (en) 1979-06-01
FI66180C (fi) 1984-09-10
DD143906A5 (de) 1980-09-17
FI66180B (fi) 1984-05-31
AU4694979A (en) 1979-11-29
HU180252B (en) 1983-02-28
NO791722L (no) 1979-11-27
DE2962124D1 (en) 1982-03-25
IL57324A (en) 1983-10-31
NZ190402A (en) 1982-05-31
FI791670A (fi) 1979-11-27
CS213377B2 (en) 1982-04-09
MW1379A1 (en) 1981-04-08
ES480932A1 (es) 1980-02-01
ZW9179A1 (en) 1981-01-21
IL57324A0 (en) 1979-09-30
ZM4579A1 (en) 1981-05-21

Similar Documents

Publication Publication Date Title
IL57324A0 (en) Triazine derivatives
NO163956C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive (4-piperidinylmetyl- og -hetero)puriner.
AU3945589A (en) Substituted 4-piperidinyl-indol-5-yl-alkyl-sulphonamide derivatives
DK491489A (da) Imidazolinderivater samt fremgangsmaade til fremstilling deraf
EP0335297A3 (de) Cephalosporinderivate
ES8305755A1 (es) Procedimiento para preparar derivados de pirimidona.
ES8307820A1 (es) Procedimiento para la obtencion de esteres del acido 7b-2-(2amino-4-tiazolil)-2-(sin)-metoxiiminoacetamido-3-cefem-4-carboxilico.
IL78954A (en) Hydantoin spirocondensed with benzopyran and quinoline derivatives and pharmaceutical compositions containing them
AU557880B2 (en) Method for modulating the immune response with dibenzocycloheptenylidenes
ES8405409A1 (es) Un procedimiento para la preparacion de derivados de b-lactama.
ES8302719A1 (es) Un procedimiento para preparar compuestos de cefem
ES8300747A1 (es) Procedimiento para la preparacion de derivados de acido in- dolacetico
DK22983A (da) Fremgangsmaade til fremstilling af penicillinderivater
AU7993982A (en) Tetra-peptide
EP0138223A3 (en) Thiazine derivatives, processes for preparation thereof and pharmaceutical conmposition comprising the same